Global Botulinum Toxin Dermal Fillers Market Size, Share, and Trends Analysis Report, By Product (Type A Botulinum Toxin and Type B Botulinum Toxin), By Application (Cosmetics and Therapeutic), By End-User (Hospitals, Specialty Clinics, and Spas & Beauty Clinics) Forecast Period (2022-2028)

The global botulinum toxin dermal fillers market is anticipated to grow at a 6.5% CAGR during the forecast period (2022-2028). The demand for minimally invasive cosmetic treatment is poised to benefit the dermal fillers and botulinum toxin market. Dermatologists prefer to treat skin diseases through less invasive procedures or topical applications in place of surgical methods. The non-procedures that witnessed a dramatic spike in popularity in 2016 were dermal fillers with hyaluronic acid and botulinum toxin. Injectable treatments are chosen due to greater awareness of measurable improvement in procedures and more information dissemination.

The most popular procedures involve the injection of botulinum toxin into the skin, which results in wrinkle reduction and volume restoration. Customers have been influenced by social and mainstream media to begin these therapies early to postpone or delay the onset of aging to the greatest extent possible. Increased healthcare spending is a clear indicator of a country’s healthcare sector improving. As a result, it suggests that numerous therapeutic and preventive procedures for disorders such as migraine, overactive bladders, hyperhidrosis, and others are available. Botox injections work by inhibiting neurotransmitters in the brain that send pain sensations. As a result, they have been shown to be effective in reducing the frequency and duration of migraine attacks in many people. As a result of the increased prevalence of these illnesses, botulinum toxin usage is expected to increase over the projection period.

Some major players in the market Allergan, Pfizer, AbbVie Inc., HUGEL, Inc., Ipsen Pharma, Medytox, Merz Pharma GmbH & Co. Merck KGaA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Recent Developments

• In March 2021, Galderma has announced that Sculptra (injectable Poly-L-lactic acid) will be re-launched in Europe with a new administration protocol.
• In January 2021, Merz Aesthetics and Candela Corporation have formed a business partnership to develop a comprehensive medical aesthetics portfolio.
• In February 2020, BioScience GmbH launched Hyaprof. Dermatologists utilize this polydensified facial filler to treat nasolabial wrinkles, oral commissures, and other facial deformities.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Allergan, Pfizer, AbbVie Inc., HUGEL, Inc., Ipsen Pharma, Medytox, Merz Pharma GmbH & Co. KGaA, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Botulinum Toxin Dermal Fillers Market Report by Segment

By Product

• Type A Botulinum Toxin
• Type B Botulinum Toxin

By Application

• Cosmetics
• Therapeutic

By End-User

• Hospitals
• Specialty Clinics
• Spas & Beauty Clinics

Global Botulinum Toxin Dermal Fillers Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa